Relation of gemfibrozil treatment and lipid levels with major coronary events : VA-HIT : A randomized controlled trial
- Author
- ROBINS, Sander J1 ; COLLINS, Dorothea2 ; RUBINS, Hanna Bloomfield10 ; WITTES, Janet T3 ; PAPADEMETRIOU, Vasilios4 ; DEEDWANIA, Prakash C5 ; SCHAEFER, Ernst J6 ; MCNAMARA, Judith R6 ; KASHYAP, Moti L7 ; HERSHMAN, Jerome M8 ; WEXLER, Laura F9
[1] Department of Medicine, Boston University School of Medicine, Boston, Mass, United States
[2] VAMC Cooperative Studies Program Coordinating Center, West Haven, Conn, United States
[3] Statistics Collaborative, washington, DC, United States
[4] Department of Medicine, Veterans Affairs Medical Centers, Washington, DC, United States
[5] Department of Medicine, Veterans Affairs Medical Centers, Fresno, Calif, United States
[6] Lipid Research Laboratory, Tufts University School of Medicine, Boston, United States
[7] Department of Medicine, Veterans Affairs Medical Centers, Long Beach, Calif, United States
[8] Department of Medicine, Veterans Affairs Medical Centers, Los Angeles, Calif, United States
[9] Department of Medicine, Veterans Affairs Medical Centers, Cincinnati, Ohio, United States
[10] Department of Medicine, Veterans Affairs Medical Centers, Minneapolis, Minn, United States
VA-HIT Study Group - Source
JAMA, the journal of the American Medical Association. 2001, Vol 285, Num 12, pp 1585-1591 ; ref : 46 ref
- ISSN
- 0098-7484
- Scientific domain
- General medicine general surgery
- Publisher
- American Medical Association, Chicago, IL
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Analyse biochimique Cardiopathie coronaire Chimiothérapie Cholestérol Complication Essai thérapeutique contrôlé Fibrate dérivé Gemfibrozil Homme Hypolipémiant Lipide Lipoprotéine HDL Mâle Prévention Randomisation Traitement Appareil circulatoire pathologie
- Keyword (en)
- Biochemical analysis Coronary heart disease Chemotherapy Cholesterol Complication Controlled therapeutic trial Fibrate derivatives Gemfibrozil Human Antilipemic agent Lipids Lipoprotein HDL Male Prevention Randomization Treatment Cardiovascular disease
- Keyword (es)
- Análisis bioquímico Cardiopatía coronaria Quimioterapia Colesterol Complicación Ensayo terapéutico controlado Fibrato derivado Gemfibrozilo Hombre Hipolipemiante Lípido Lipoproteina HDL Macho Prevención Aleatorización Tratamiento Aparato circulatorio patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02N General and cellular metabolism. Vitamins
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 942238
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1001/jama.285.12.1585 
https://dx.doi.org/10.1001/jama.285.12.1585
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1001\/jama.285.12.1585\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:118:\"Relation of gemfibrozil treatment and lipid levels with major coronary events : VA-HIT : A randomized controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:53:\"JAMA, the journal of the American Medical Association\";s:9:\"\u0000*\u0000stitle\";s:22:\"JAMA j. Am. Med. Assoc\";s:7:\"\u0000*\u0000date\";s:4:\"2001\";s:9:\"\u0000*\u0000volume\";s:3:\"285\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"1585\";s:8:\"\u0000*\u0000epage\";s:4:\"1591\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0098-7484\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"ROBINS\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Sander J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:17:\"COLLINS, Dorothea\";i:1;s:24:\"RUBINS, Hanna Bloomfield\";i:2;s:15:\"WITTES, Janet T\";i:3;s:23:\"PAPADEMETRIOU, Vasilios\";i:4;s:20:\"DEEDWANIA, Prakash C\";i:5;s:17:\"SCHAEFER, Ernst J\";i:6;s:18:\"MCNAMARA, Judith R\";i:7;s:15:\"KASHYAP, Moti L\";i:8;s:18:\"HERSHMAN, Jerome M\";i:9;s:15:\"WEXLER, Laura F\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:118:\"Relation of gemfibrozil treatment and lipid levels with major coronary events : VA-HIT : A randomized controlled trial\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1001\/jama.285.12.1585\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:118:\"Relation of gemfibrozil treatment and lipid levels with major coronary events : VA-HIT : A randomized controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:53:\"JAMA, the journal of the American Medical Association\";s:9:\"\u0000*\u0000stitle\";s:22:\"JAMA j. Am. Med. Assoc\";s:7:\"\u0000*\u0000date\";s:4:\"2001\";s:9:\"\u0000*\u0000volume\";s:3:\"285\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"1585\";s:8:\"\u0000*\u0000epage\";s:4:\"1591\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0098-7484\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"ROBINS\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Sander J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:17:\"COLLINS, Dorothea\";i:1;s:24:\"RUBINS, Hanna Bloomfield\";i:2;s:15:\"WITTES, Janet T\";i:3;s:23:\"PAPADEMETRIOU, Vasilios\";i:4;s:20:\"DEEDWANIA, Prakash C\";i:5;s:17:\"SCHAEFER, Ernst J\";i:6;s:18:\"MCNAMARA, Judith R\";i:7;s:15:\"KASHYAP, Moti L\";i:8;s:18:\"HERSHMAN, Jerome M\";i:9;s:15:\"WEXLER, Laura F\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:118:\"Relation of gemfibrozil treatment and lipid levels with major coronary events : VA-HIT : A randomized controlled trial\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:24:\"10.1001\/jama.285.12.1585\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1001\/jama.285.12.1585\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:118:\"Relation of gemfibrozil treatment and lipid levels with major coronary events : VA-HIT : A randomized controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:53:\"JAMA, the journal of the American Medical Association\";s:9:\"\u0000*\u0000stitle\";s:22:\"JAMA j. Am. Med. Assoc\";s:7:\"\u0000*\u0000date\";s:4:\"2001\";s:9:\"\u0000*\u0000volume\";s:3:\"285\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"1585\";s:8:\"\u0000*\u0000epage\";s:4:\"1591\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0098-7484\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"ROBINS\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Sander J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:17:\"COLLINS, Dorothea\";i:1;s:24:\"RUBINS, Hanna Bloomfield\";i:2;s:15:\"WITTES, Janet T\";i:3;s:23:\"PAPADEMETRIOU, Vasilios\";i:4;s:20:\"DEEDWANIA, Prakash C\";i:5;s:17:\"SCHAEFER, Ernst J\";i:6;s:18:\"MCNAMARA, Judith R\";i:7;s:15:\"KASHYAP, Moti L\";i:8;s:18:\"HERSHMAN, Jerome M\";i:9;s:15:\"WEXLER, Laura F\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:118:\"Relation of gemfibrozil treatment and lipid levels with major coronary events : VA-HIT : A randomized controlled trial\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1001\/jama.285.12.1585\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:118:\"Relation of gemfibrozil treatment and lipid levels with major coronary events : VA-HIT : A randomized controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:53:\"JAMA, the journal of the American Medical Association\";s:9:\"\u0000*\u0000stitle\";s:22:\"JAMA j. Am. Med. Assoc\";s:7:\"\u0000*\u0000date\";s:4:\"2001\";s:9:\"\u0000*\u0000volume\";s:3:\"285\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"1585\";s:8:\"\u0000*\u0000epage\";s:4:\"1591\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0098-7484\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"ROBINS\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Sander J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:17:\"COLLINS, Dorothea\";i:1;s:24:\"RUBINS, Hanna Bloomfield\";i:2;s:15:\"WITTES, Janet T\";i:3;s:23:\"PAPADEMETRIOU, Vasilios\";i:4;s:20:\"DEEDWANIA, Prakash C\";i:5;s:17:\"SCHAEFER, Ernst J\";i:6;s:18:\"MCNAMARA, Judith R\";i:7;s:15:\"KASHYAP, Moti L\";i:8;s:18:\"HERSHMAN, Jerome M\";i:9;s:15:\"WEXLER, Laura F\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:118:\"Relation of gemfibrozil treatment and lipid levels with major coronary events : VA-HIT : A randomized controlled trial\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1001\/jama.285.12.1585\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:118:\"Relation of gemfibrozil treatment and lipid levels with major coronary events : VA-HIT : A randomized controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:53:\"JAMA, the journal of the American Medical Association\";s:9:\"\u0000*\u0000stitle\";s:22:\"JAMA j. Am. Med. Assoc\";s:7:\"\u0000*\u0000date\";s:4:\"2001\";s:9:\"\u0000*\u0000volume\";s:3:\"285\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"1585\";s:8:\"\u0000*\u0000epage\";s:4:\"1591\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0098-7484\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"ROBINS\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Sander J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:17:\"COLLINS, Dorothea\";i:1;s:24:\"RUBINS, Hanna Bloomfield\";i:2;s:15:\"WITTES, Janet T\";i:3;s:23:\"PAPADEMETRIOU, Vasilios\";i:4;s:20:\"DEEDWANIA, Prakash C\";i:5;s:17:\"SCHAEFER, Ernst J\";i:6;s:18:\"MCNAMARA, Judith R\";i:7;s:15:\"KASHYAP, Moti L\";i:8;s:18:\"HERSHMAN, Jerome M\";i:9;s:15:\"WEXLER, Laura F\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:118:\"Relation of gemfibrozil treatment and lipid levels with major coronary events : VA-HIT : A randomized controlled trial\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
